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Distinct 6-phosphofructo-2-kinase (PFK_2)/fructose 2,6_bisphosphatase (FBPase-2) cDNAs were cloned from bovine heart, showing that PFK-2/ 
FBPase-2 gene B, which contains 16 exons, codes for at least five mRNAs. Three of them (Bl, B2, B4) could encode the 58,000-nci, isozyme. In 
B2 mRNA. exon 15 encodes four more restdues than in Bl, In B4 mRNA, exon 15 encodes six more residues than in Bl~ but exon 16 (20 residues) 
is missing. 83 mRNA corresponds to the 54.000-M, isozyme. It lacks exon 15 and also differs from the other mRNAs in the 5’ noncoding region. 
B5 mRNA encodes a truncated form. When expressed m E. co/i. the recombmant isoforms correspondmg to all these mRNAs except B5 exhibited 
PFK-2 activity. 
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1. INTRODUCTION 
The synthesis and degradation of fructose-2,6-bis- 
phosphate, a potent stimulator of 6-phosphofructo-l- 
kinase, are catalyzed by 6-phosphofructo-2-kinase 
(PFK-2, EC 2.7.1.105) and fructose-2,6_bisphosphatase 
(FBPase-2, EC 3.1.3.46) respectively. These two activi- 
ties are borne by each subunit of the homodimeric bi- 
functional enzyme PFK-2/FBPase-2. The existence of 
several PFK-2/FBPase-2 isozymes that differ in tissue- 
specific expression and response to hormonal signals [l] 
provides a mechanism for the local and temporal con- 
trol of glycolysis. Changes in heart glycolysis in re- 
sponse to substrates such as glucose and ketone bodies, 
to epinephrine and insulin, and to workload correlate 
with changes in fructose-2,6-bisphosphate concentra- 
tion [2-51. Bovine heart PFK-2/FBPase-2 is 
phosphorylated on multiple sites by CAMP-dependent 
protein kinase (PKA), which stimulates PFK-2 activity, 
by protein kinase C (PKC), and by Ca”-calmodulin 
kinase [5-71. Analysis of purified bovine heart PFK-2/ 
FBPase-2 by SDS/PAGE revealed two isozymes with 
M, values of 58,000 and 54,000 [8]. These isozymes 
derive from the same gene, called gene B [9], by alterna- 
tive splicing [lO,l 11, the smaller isozyme lacking a pep- 
tide that contains sites for phosphorylation by PKA and 
PKC. This peptide corresponds to exon 15 of the rat 
gene, which contains 16 exons [9]. A cDNA fully coding 
for bovine heart PFK-2/FBPase-2 and containing exon 
15 has been described [12]. This cDNA predicts a sub- 
unit of 60,679 Da, Removal of exon 15 would yield a 
subunit of 53,909 Da. We decided to clone the mRNAs 
encoding the 54.000- and 58,000-M, isozymes and to 
express them separately. In the course of this work, we 
discovered that bovine heart actually contains at last 
five PFK-2/FBPase-2 mRNAs that differ in coding se- 
quence. 
2. EXPERIMENTAL 
*Corresponding author. Fax: (32) (2) 762 7455. 2.1. A4aterrals 
**Present address. INSERM U.197, Faculte de Medecine Alexis Car- 
rel, 69008 Lyon, France. 
***The followmg accession numbers have been assigned to the se- 
quences mentioned in thts article: X74563 applies to B taurus (clone 
24) mRNA for 6-phosphofructo-2-kinase, exon 1; and X74564 applies 
to B. taurus (clone 15-2) mRNA for 6-phosphofructo-2-kinase, 
exon 1. 
Bacterial media were from Gibco-BRL. Hybond N’ membranes. 
[a-3ZP]dCTP, [35S]dATPaS, T7 DNA polymerase and T4 DNA ligase 
were from Amersham. The pBluescript (KS)II+ phagemid and the E. 
colr cloning host XLl-Blue were from Stratagene. The helper phage 
R408 was from Promega. The expression vector pET3a and the E. coli 
hosts BL21(DE3), BL21(DE3)pLysE and BLZl(DE3)pLysS. were 
gifts from Dr. Studier [13]. Restriction enzymes were from Boehrmger 
and synthetic oligonucleotides were from Pharmacia LKB Biotechnol- 
ogy Inc. Other reagents were from Boehringer or Sigma. 
Abbrewations, FBPase-2, fructose-2,6_bisphosphatase; ORF. open 
reading frame, PCR, polymerase chain reaction; PFK-2. 6- 
phosphofructo-2-kinase; PKA. cyclic AMP-dependent protein kmase; 
PKC: protein kinase C. 
2.2. Library screening and sequencing of bovine heart PFK-2lFBPaseZ 
clones 
The jlgt 11 bovine heart cDNA library (from Clontech) was screened 
by hybridization to a rat heart cDNA probe (RHl-9) corresponding 
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to exons 1 to 9 of PFK-YFBPase-3 gene B [9]. The probe was labeled 
with [cr-“P]dCTP using a random ohgo-labeling kit (Amersham) and 
was hybridized overnight at 65°C in 3.5 x SSC. 0.5% SDS. 2 mM 
EDTA, 25 mM sodium phosphate and 1 x Denhardt’s solution m the 
presence of herring sperm DNA at lOO,@ml[l4]. Phage plaques were 
purified and cDNA inserts were subcloned m pBluescript and se- 
quenced using the reagents from US Biochemicals, except that Se- 
quenase was replaced by T7 DNA polymerase. Preparation of total 
bovine heart RNA, reverse transcription and polymerase chain reac- 
tion (PCR) were performed [I I] with the oligonucleotides described 
in the text. 
2.3. Dwrcred n~u~ugencs~~ and comtructwn of t/w e.~prrssron plasrmd.c 
Fully coding cDNAs corresponding to each isoform were reconsti- 
tuted in the (+) strand of pBluescrtpt. Clone IS-2 was chosen to 
provide the left half of all the isoforms I e. from the ATG imttation 
codon m exon 2 to the &oRI site located 438 nucleotides downstream 
from it Clone 18-2 was first mutated [15] with an Amersham kit to 
insert H~rtdIIllh7&I sites Just before the unttatton codon The coding 
sequence (exons 226) was isolated after HlndIIIIEc~~RI digestion and 
Inserted in pBluescript m the (+) orientation, yielding the MUTlS-2 
phagemid Clones correspondmg to the right half of the isoforms. t.e 
from EcoRI to the 3’-end of the cDNAs. were mutated to insert a 
Bar>rHI site Just downstream from the stop codon. The fragments 
contammg the codmg sequence uere excised by EuJRI~BuI~IHI diges- 
tion and inserted into MUTIS-2 to produce the fully coding phagem- 
ids. All mutagenesis and subclonmg procedures mere verified by se- 
quencmg. The inserts correspondmg to the fully coding sequence of 
each isoform nere purified after restriction by ,‘vJcI and BtrrrlHl and 
hgated individually in the pET3a plasmid. E coli of the BL21 strain 
were transformed with these expresston vectors and recombmant pro- 
tem expresston was induced with isopropyl P-n-thiogalactopyra- 
noside. 
3. RESULTS 
3.1. Characterization of the rnRNAs 
At the tertiary screening of the bovine heart cDNA 
library with the RHl-9 probe 28 positive out of 
1.3 x 10h clones were obtained. The positive clones were 
classified by hybridization with oligonucleotide probes, 
one specific for exon 5, one for exon 15, and one for 
exon 16. Seven clones were positive with the three 
probes, two with the probes for exons 5 and 16. six with 
the probes for exons 5 and 15, and thirteen with the 
probe for exon 5. Subcloning and sequencing of clones 
representative of these four families showed that, be- 
sides the mRNA cloned by Sakata and Uyeda [12], there 
exist at least four other types of heart PFK-2/FBPase-2 
mRNAs. The data in Fig. 1 show how the novel 
mRNAs identified here (B2 to B5) differ from the one 
(Bl) characterized earlier [12]. A comparison of their 
cDNA sequence with that of gene B [9] showed that they 
all derive from gene B. hence the nomenclature pro- 
posed. 
B2 mRNA is identical to Bl except for 12 nucleotides 
at the junction between exons 15 and 16 (Fig. 1). This 
results from the use of a more distal splice site in exon 
15 (Fig. 2). which is therefore called 15a in Bl mRNA 
and 15b in B2 mRNA. Thus. B2 mRNA encodes a 
peptide (H61) four residues longer than that (H60) 
coded by B 1 mRNA (530 residues). 
mRNA 
I kb 
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Fig 1. Structure of the mRNAs for the heart isoforms of 6-phosphofructo-2-klnase/fructose-3.6-b]spho5phatase. The boxes, m which numbers 
designate the exons. correspond to the mRNAs Hatched lanes and lower case letters refer to sequences that differ between the mRNAs: m. mtron. 
The lines between the boxes correspond to the cDNA clones. Clones 9G and 7H were described earher [12]. E. GoRI: A. .draI: S. S(rtI. The number 
of residues and molecular mass of peptides encoded by the ORFs discounts the mmal methionme 
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rat gem 5’.CAG CCG AAG ACC CAA GTC AGC ATT CCG GTG GTG rci\ CTG TGT GE TCC 3 
clone 42 S-CAG CCG AAG ACC CAA GTC AGC ATT CCG,GTG GTG TAA CCG TGT GCT TCC --- 3’ 
e\on 15a can I6 
S-CAG CCG AAG ACC CAA 
I%? 7H ,506Z~( 
GCA GAG ACC TCG CGG ----CCC TCC -Q%J tgg ctg ---3 
Ala Glu Thr %r Arg ---- Pro Ser Stop (5301 
cxon 15b exon 16 
clone R S’CAG CCG AAG ACC CAA GTC AK ATT CCG GCA GAG ACC TCG CGG ----CCC TCCmtgg ctg --- 3’ 
Hbl (506) Gln Pro Lys Thr Gin Val Ser Ile Pro Ala Glu Thr Ser Arg ---- Pro Ser Stop (534) 
end cl”“e JR 
exon 15c J. 
clone 18: 5’.CAG CCG AAG ACC CAA GTC AGC ATT CCC. GTG GTG m <cg tgt get tee --- 3 
H59 (506) Gln Pro Lvs Thr Gin Val Ser Ile Pro Val Val Stop(516) 
Fig. 2. C-terminal organizatton of the H60. H61 and H59 isoforms m the coding region. The upper lme refers to the rat gene sequence m the exon 
15 region, where the mismatches with the sequence of clone 42 are overlined. Arrows indtcate the posttton of the sphce sites, Numbers in parentheses 
refer to uosttton of the residue. To save snace, 13 residues have been omitted wtthm the sequence of exon 16. The sequence of clone 7H is from 
u21 
B3 mRNA does not contain exon 15. reducing the 
predicted peptide (H54) to 470 residues. Its mass 
(53,909 Da) fits with the subunit M, of 54,000 deter- 
mined for the smaller heart isozyme. Its sequence indeed 
contains the peptides that we identified by microse- 
quencing of the 54,000-M, isozyme [l 11. B3 mRNA also 
differs from the other mRNAs at the 5’ end, upstream 
from the 21 nucleotides that precede the AUG initiation 
codon. Thus, B3 mRNA contains an alternative 5’ non- 
coding exon (exon 1’) so that it could arise from a 
different primary transcript of gene B through use of 
another promoter. Alternatively, all the mRNAs de- 
scribed here could derive from a single primary tran- 
script starting with (a) common noncoding exon( s). not 
present in our cDNAs, spliced with either exon 1 or 
exon 1’. 
The sequence of the cDNA corresponding to B4 
mRNA was identical to that of B2 mRNA except that 
it ended on the 3’ side one nucleotide (G) beyond exon 
15b (Fig. 2). Four out of the six clones that were positive 
with the probes for exons 5 and 15 were sequenced: all 
terminated at this same nucleotide. The presence of the 
EcoRI linker (CCCGAATTC) used to construct the 
library just after this G indicated that these clones ended 
prematurely because of a cloning artifact. We investi- 
gated whether this G was the first of a broken exon 16, 
or was followed by a novel coding sequence. or else 
belonged to an extended version of exon 15b, in which 
case gene B predicts a stop codon six nucleotides down- 
stream (Fig. 2). The latter possibility was examined for 
three reasons. First, it predicted a C-terminal sequence 
(VSIPVV) identical to that of a PFK-2/FBPase-2 de- 
rived from a rat heart cDNA [16]. Second, the predicted 
peptide had a size (59,267 Da) close to that of the 
58,000-M, isozyme. Third, it fitted with the sequence of 
our clone 42, which extends further downstream than 
clone 18 and is devoid of exon 16. To test these hypoth- 
eses we amplified by PCR a cDNA obtained on total 
heart RNA by reverse transcription from a primer (A 
in Fig. 3) complementary to a sequence of clone 42 
located 66 nucleotides downstream from the putative 
TAA stop codon. Amplification between primer C, cor- 
responding to a sequence in exon 13, and primer B, 
located just 5’ to primer A. yielded the expected band 
of 374 nucleotides and a band of 113 nucleotides (Fig. 
3). These PCR products were cloned and sequenced. 
The 113-nucleotide band was nonspecific, while the se- 
quence of the 374 nucleotide-long product perfectly 
matched the expected one. This supports the existence, 
in bovine heart, of a mRNA (B4) coding for a PFK-2/ 
FBPase-2 isoform that contains an extended version of 
exon 15 and is devoid of exon 16. The stop codon is 
located in exon 15 (Fig. 2). which is longer than in B2 
mRNA and is therefore called here 15~ (Figs. 1 and 2). 
The peptide (H59) predicted from B4 mRNA is 516 
residues long and is 59,267 Da. This is closer to the 
58,000-M, isozyme described in bovine heart than the 
longer peptides predicted from Bl and B2 mRNAs. 
The sequence of clone 42 predicted an mRNA similar 
to that of B4 mRNA, i.e. with exon 15~ and without 
exon 16. However, exon 8 was missing, leading to a 
change of reading frame in exon 9 where a stop codon 
is encountered after 177 nucleotides. In addition, clone 
42 lacked a TGT codon. which corresponds to Cy? at 
the end of exon 2. This deletion, which does not change 
the ORF, probably results from the choice of another 
splice site, exon 2 being replaced by a slightly shorter 
version called here exon 2a. The ORF resulting from the 
lack of exon 8 predicts a peptide (H26) of 227 residues 
(25.958 Da) whose sequence is identical to the first 168 
residues of the other isoforms described above, without 
Cys’*, followed by an unrelated sequence of 59 residues: 
(169)GSFFHQGDKRGPEISREQSPGLHPEQDRLL- 
PHEYPRPPSHHLPLPAWRERVQPLGEDWG(227). 
This truncated isoform is expected to lack PFK-2 and 
FBPase-2 activity. Indeed, some of the residues that are 
essential for PFK-2 activity are located between posi- 
tions 168 and 250, while the FBPase-2 domain starts 
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beyond position 250 [17]. Finally, the 3’ noncoding se- 
quence of clone 42 was interrupted between exons 13 
and 14 (Fig. 1) by 252 nucleotides that correspond to 
intron 111 of gene B [9]. 
3.2. E.upression of the isoforms 
To express the different isoforms as recombinant pro- 
teins, the relevant parts of the cDNA clones were iso- 
lated from pBluescript and fully coding cDNAs were 
reconstituted in the (+) strand to obtain at the same time 
a tool for future site-directed mutagenesis of the 
isoforms. Phagemid B2 was constructed by inserting the 
coding sequence of the BanlHI-mutated clone 8-l into 
the MUTl8-2 phagemid (see Section 2). Phagemid Bl 
was obtained in the same way except that clone 8-l 
underwent a second directed mutagenesis with a 29-mer 
oligonucleotide to delete the 12 bp that make the differ- 
ence between exon 15b and exon 15a. For phagemid B3, 
the mutagenesis failed. Instead of introducing a BarnHI 
site, we therefore used the AvaI site in clone 15-1, lo- 
cated 123 nucleotides downstream from the stop codon. 
Phagemid B4 was constructed by inserting into 
MUTl8-2 clone 18-l to which the 5 nucleotides and the 
stop codon missing at the end of exon 15c, followed by 
a BanrHI site, were added by mutagenesis using a 40- 
mer oligonucleotide. In phagemid B5, we inserted the 
cDNA sequence encoding the truncated peptide by 
cloning in MUTl8-2 a fragment of clone 42- 1 extending 
from the EcoRI site to a StuI site located 5 nucleotides 
beyond the stop codon of the ORF. 
BL21 bacteria were transformed with the appropriate 
pET3a vectors and expression of the different isoforms 
was induced. PFK-2 activity. which is absent in untrans- 
formed bacteria, was assayed in bacterial lysates pre- 
pared as described [ 181. The results of Table I show that 
13 14 15 TAA 
5’ I I 1 3' -- 
CI 374 --------tB A 
369 - - 374 
246 - 
123 - - 113 
Fig. 3. Characterization by PCR of the C-terminus of the H59 isoform. 
Ethidium bromide staining of the 2% agarose gel electrophoresis of 
the PCR products with the nucleotide ladder on the left The relevant 
regton of mRNA B4 is depicted, with exons 13. 14 and l5c indicated 
A. B and C correspond to the oligonuclcotide prtmers used. The 
number between arrows refers to the number of nucleotides expected 
from the cDNA sequence 
Table I 
PFK-3 activity m the supernatant of lysates of E. cnll transformed with 
the recombinant heart isoforms 
Isoform Activity Specific 
acttvity 
Recovery in PFK-2 per I of 
supernatant culture* 
mumt mumt/mg 
protein 
9 umt mg 
H60 111 4.6 80 2.4 48 
H61 IO2 45 87 2.3 46 
H54 17 0.8 18 0.4 8 
H59 78 2.5 85 I.7 34 
H26 0 0 0 0 0 
Measurements were made on 45 ml of culture. One unit corresponds 
to the formation of 1 pmol of product per min. 
*Calculated assuming the specific activtty of pure enzyme is 50 mU/mg 
[S.llI 
all the isoforms , except H26. exhibited PFK-2 activity 
as expected from their predicted sequence. The presence 
of the H26 isoform in the lysate was confirmed by West- 
ern blotting using an antibody directed against a syn- 
thetic peptide corresponding to residues 18 l-193, which 
are located in the specific region of this isoform (data 
not shown). Almost all the PFK-2 activity was recov- 
ered in the supernatant of the lysates for the H61, H60 
and H59 isoforms. while that of the H54 isoform was 
mainly found in inclusion bodies. This could result from 
the decrease in overall charge of the protein (-2 for H54 
vs. +5 for H61 and H60 and +4 for H.59, at pH 7), due 
to the absence in H54 of the 60 residues coded by exon 
15. Purification of these isoforms in order to determine 
their individual kinetic properties is in progress. 
4. DISCUSSION 
Biochemical studies have defined in bovine heart two 
PFK-2/FBPase-2 isozymes with subunit A4, of 58,000 
and 54,000 [8]. The cDNA cloned earlier from that 
tissue, which corresponds to mRNA Bl, predicts a pep- 
tide (H60) of 60,679 Da [ 121 and is encoded by 16 exons 
of gene B [9]. We report here a novel cDNA predicting 
a mRNA (B2) and a peptide (H61) with four additional 
residues because of the use of distinct splice sites at the 
end of exon 15. We also demonstrate by PCR that 
bovine heart contains a mRNA (B4) in which none of 
these splice sites is used and is therefore devoid of exon 
16. This mRNA encodes a peptide (H59) of 59,267 Da. 
Thus, at least three peptides (H61, H60, H59), which 
probably originate from the same primary transcript, 
may account for the 58,000-Mr isoform of bovine heart 
PFK-YFBPase-2. Which of these three isoforms is ex- 
pressed in vivo is unknown. H59 is the more likely 
candidate because its molecular mass is close to that of 
the purified protein and its C-terminal sequence corre- 
sponds to that of rat heart PFK-2/FBPase-2 [16]. Be- 
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cause of splicing with exon 16, the sequence coded by 
exon 15 is shorter (by 2 residues) in H61, and even 
shorter (by 6 residues) in H60, than in the H59 isoform. 
Although these deletions do not contain the phospho- 
rylation sites, the absence of ProsI in H60 might influ- 
ence the flexibility of the peptide in this region. It is also 
of interest that the 3’ trailer of the mRNAs bearing exon 
16 (Bl, B2 and B3) differs from that of B4 mRNA. 
Because the 3’ end of the mRNA contains signals that 
control mRNA stability, translation and/or location 
within the cell [19], this difference might influence the 
expression of the 58,000-Mr isoform of PFK-2/FBPase- 
2 in heart. 
Using PCR and microsequencing strategies, the 
54,000-Mr isozyme was identified earlier as a product 
of gene B but lacking exon 15, which results in the 
deletion of 60 amino acids [lO,l 11. We have now cloned 
the cDNA corresponding to the mRNA (B3) coding for 
this short isozyme (called here the H54 isoform) and 
confirmed that it results from the splicing of exon 14 
with exon 16. This probably leads to differences in sen- 
sitivity to regulatory signals between H54 and the other 
isoforms. Indeed, exon 15 codes for Ser466 which is 
phosphorylated by PKA and PKC, for Thr4” which is 
phosphorylated by PKC, and for Ser483 which is 
phosphorylated by PKA [7,8,11]. Thus, the H54 
isoform lacks all these sites although it still shares with 
the H59, H60 and H61 isoforms SerR4, which is 
phosphorylated by PKC [7]. The difference in C-termi- 
nal sequences also bears on the overall subunit charge 
(see above), which is liable to change upon phosphoryl- 
ation. 
The structure of B5 mRNA, originating from the 
same primary transcript as the H61, H60 and H59 
isoforms, predicts a truncated peptide called here H26. 
This peptide entails exons 2 to 9 with loss of exon 8 and 
of residues that are essential for PFK-2 activity. The 
recombinant protein indeed lacked PFK-2 activity. We 
have detected a BS-type mRNA in rat heart and other 
tissues (unpublished). 
Although none of our cDNA clones ends with a 
poly(A) tail, the overall length of the mRNAs derived 
from them (3.9 kb) is close to that (about 4 kb) deter- 
mined by Northern blot analysis of bovine heart RNA 
[12]. These clones now provide about 1.65 kb of addi- 
tional sequence in the identical 3’ trailer of the mRNAs 
Bl, B2 and B3, and almost all (1.9 kb) the 3’ trailer of 
the mRNAs B4 and B5. A comparison of their sequence 
with that of the rat gene B [9] failed to reveal a 3’ coding 
exon that would match the ORF found beyond exon 15 
in that gene. Likewise, no ORF corresponding to the 
bovine exon 16 has been identified so far in the rat gene. 
This comparison also shows the occurrence in bovine 
heart PFK-2/FBPase-2 mRNAs of a 5’ noncoding exon 
as is the case in the rat. The clones described here extend 
the known sequence of exon 1 from 5 bp [12] to 330 bp 
and yield 41 bp of the novel exon 1’. They also provide 
tools to investigate the short-term and long-term regula- 
tion of PFK-2/FBPase-2 in heart. Glycolysis in this tis- 
sue may require regional control within the organ [20]. 
The different PFK-2/FBPase-2 isoforms characterized 
here might participate in this control. 
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